Aptevo Therapeutics
APVO
APVO
8 hedge funds and large institutions have $5M invested in Aptevo Therapeutics in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
Holders
8
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$519K | |
| 2 | +$495K | |
| 3 | +$412K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$308K |
Top Sellers
| 1 | -$1.32M | |
| 2 | -$292K | |
| 3 | -$95K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$89K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$83K |